Herman Goossens

Author PubWeight™ 216.28‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Antibiotic resistance-the need for global solutions. Lancet Infect Dis 2013 15.01
2 EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology 2012 4.83
3 International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections. Ann Intern Med 2004 4.75
4 Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. Lancet Infect Dis 2012 4.62
5 Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerg Infect Dis 2002 4.08
6 European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl 2012 3.98
7 Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. Clin Infect Dis 2004 3.75
8 Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infect Dis 2010 3.65
9 Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study. Lancet 2007 3.44
10 Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action. Antimicrob Resist Infect Control 2012 3.02
11 Effects of internet-based training on antibiotic prescribing rates for acute respiratory-tract infections: a multinational, cluster, randomised, factorial, controlled trial. Lancet 2013 2.83
12 Antimicrobial drug use and resistance in Europe. Emerg Infect Dis 2008 2.68
13 European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997-2009). J Antimicrob Chemother 2011 2.58
14 Society's failure to protect a precious resource: antibiotics. Lancet 2011 2.51
15 Virulence characteristics of Klebsiella and clinical manifestations of K. pneumoniae bloodstream infections. Emerg Infect Dis 2007 2.49
16 Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut 2012 2.49
17 Use of serum C reactive protein and procalcitonin concentrations in addition to symptoms and signs to predict pneumonia in patients presenting to primary care with acute cough: diagnostic study. BMJ 2013 2.40
18 European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. J Antimicrob Chemother 2006 2.32
19 A potential virulence gene, hylEfm, predominates in Enterococcus faecium of clinical origin. J Infect Dis 2003 2.29
20 Development of a multiplex PCR for the detection of asa1, gelE, cylA, esp, and hyl genes in enterococci and survey for virulence determinants among European hospital isolates of Enterococcus faecium. J Clin Microbiol 2004 2.10
21 Prevalence and resistance of commensal Staphylococcus aureus, including meticillin-resistant S aureus, in nine European countries: a cross-sectional study. Lancet Infect Dis 2013 2.04
22 Appropriate international measures for outpatient antibiotic prescribing and consumption: recommendations from a national data comparison of different measures. J Antimicrob Chemother 2013 2.04
23 Comparison and evaluation of real-time PCR, real-time nucleic acid sequence-based amplification, conventional PCR, and serology for diagnosis of Mycoplasma pneumoniae. J Clin Microbiol 2003 1.87
24 Evaluation of real-time PCR for detection of and discrimination between Bordetella pertussis, Bordetella parapertussis, and Bordetella holmesii for clinical diagnosis. J Clin Microbiol 2003 1.85
25 Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination. Proc Natl Acad Sci U S A 2010 1.84
26 Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium, June 2016. Euro Surveill 2016 1.84
27 Current trends in rapid diagnostics for methicillin-resistant Staphylococcus aureus and glycopeptide-resistant enterococcus species. J Clin Microbiol 2008 1.81
28 In vitro antibacterial activity of the ceftazidime-avibactam (NXL104) combination against Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother 2012 1.59
29 The European surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006. Clin Infect Dis 2009 1.53
30 Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data. J Antimicrob Chemother 2007 1.53
31 Current trends in culture-based and molecular detection of extended-spectrum-β-lactamase-harboring and carbapenem-resistant Enterobacteriaceae. J Clin Microbiol 2012 1.52
32 Isolation and characterization of current human coronavirus strains in primary human epithelial cell cultures reveal differences in target cell tropism. J Virol 2013 1.47
33 Evaluation of new broth media for microdilution antibiotic susceptibility testing of Lactobacilli, Pediococci, Lactococci, and Bifidobacteria. Appl Environ Microbiol 2005 1.47
34 Severity assessment for lower respiratory tract infections: potential use and validity of the CRB-65 in primary care. Prim Care Respir J 2012 1.46
35 A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis 2014 1.46
36 Towards clinical definitions of lower respiratory tract infection (LRTI) for research and primary care practice in Europe: an international consensus study. Prim Care Respir J 2011 1.45
37 Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the "gold standard". J Clin Microbiol 2005 1.45
38 Detection of Mycoplasma pneumoniae in respiratory samples by real-time PCR using an inhibition control. J Microbiol Methods 2003 1.44
39 Multiplex PCR for simultaneous detection of macrolide and tetracycline resistance determinants in streptococci. Antimicrob Agents Chemother 2005 1.42
40 Development and clinical evaluation of an internally controlled, single-tube multiplex real-time PCR assay for detection of Legionella pneumophila and other Legionella species. J Clin Microbiol 2003 1.40
41 'The body gets used to them': patients' interpretations of antibiotic resistance and the implications for containment strategies. J Gen Intern Med 2011 1.39
42 Community acquired pneumonia in primary care. BMJ 2006 1.35
43 A sensitive assay for virus discovery in respiratory clinical samples. PLoS One 2011 1.33
44 European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe. Qual Saf Health Care 2007 1.32
45 Antimicrobial susceptibilities of Lactobacillus, Pediococcus and Lactococcus human isolates and cultures intended for probiotic or nutritional use. J Antimicrob Chemother 2007 1.32
46 Differences in gut microbiota composition between obese and lean children: a cross-sectional study. Gut Pathog 2013 1.30
47 Evaluation of chromogenic media for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2010 1.30
48 European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe. J Antimicrob Chemother 2006 1.29
49 European Surveillance of Antimicrobial Consumption (ESAC): disease-specific quality indicators for outpatient antibiotic prescribing. BMJ Qual Saf 2011 1.27
50 Antibiotics for acute cough: an international observational study of patient adherence in primary care. Br J Gen Pract 2012 1.25
51 Identification of targets for quality improvement in antimicrobial prescribing: the web-based ESAC Point Prevalence Survey 2009. J Antimicrob Chemother 2010 1.23
52 Antibiotic use in ambulatory care in Europe (ESAC data 1997-2002): trends, regional differences and seasonal fluctuations. Pharmacoepidemiol Drug Saf 2007 1.21
53 Association between antibiotic sales and public campaigns for their appropriate use. JAMA 2004 1.20
54 Understanding variation in primary medical care: a nine-country qualitative study of clinicians' accounts of the non-clinical factors that shape antibiotic prescribing decisions for lower respiratory tract infection. BMJ Open 2012 1.19
55 A multi-country qualitative study of clinicians' and patients' views on point of care tests for lower respiratory tract infection. Fam Pract 2011 1.16
56 General practitioners' views on the acceptability and applicability of a web-based intervention to reduce antibiotic prescribing for acute cough in multiple European countries: a qualitative study prior to a randomised trial. BMC Fam Pract 2012 1.15
57 Primary care clinicians' perceptions of antibiotic resistance: a multi-country qualitative interview study. J Antimicrob Chemother 2012 1.15
58 Herpes simplex virus in the respiratory tract of critical care patients: a prospective study. Lancet 2003 1.15
59 Clonal spread of fluoroquinolone non-susceptible Streptococcus pyogenes. J Antimicrob Chemother 2005 1.12
60 Macrolide- and telithromycin-resistant Streptococcus pyogenes, Belgium, 1999-2003. Emerg Infect Dis 2005 1.12
61 Diagnostics as essential tools for containing antibacterial resistance. Drug Resist Updat 2011 1.12
62 Are patient views about antibiotics related to clinician perceptions, management and outcome? A multi-country study in outpatients with acute cough. PLoS One 2013 1.11
63 Comparison of strategies to reduce meticillin-resistant Staphylococcus aureus rates in surgical patients: a controlled multicentre intervention trial. BMJ Open 2013 1.11
64 Bacitracin-resistant clone of Streptococcus pyogenes isolated from pharyngitis patients in Belgium. J Clin Microbiol 2003 1.10
65 European Surveillance of Antimicrobial Consumption (ESAC): quality appraisal of antibiotic use in Europe. J Antimicrob Chemother 2011 1.10
66 Clinicians' views and experiences of interventions to enhance the quality of antibiotic prescribing for acute respiratory tract infections. J Gen Intern Med 2014 1.10
67 Priority actions to fight antibiotic resistance: results of an international meeting. Antimicrob Resist Infect Control 2012 1.10
68 The appropriateness of prescribing antibiotics in the community in Europe: study design. BMC Infect Dis 2011 1.08
69 Denaturing gradient gel electrophoresis of neonatal intestinal microbiota in relation to the development of asthma. BMC Microbiol 2011 1.08
70 Socioeconomic determinants of outpatient antibiotic use in Europe. Int J Public Health 2010 1.08
71 European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997-2009). J Antimicrob Chemother 2011 1.08
72 Accuracy of species identity of commercial bacterial cultures intended for probiotic or nutritional use. Res Microbiol 2006 1.07
73 European Surveillance of Antimicrobial Consumption (ESAC): value of a point-prevalence survey of antimicrobial use across Europe. Drugs 2011 1.06
74 IFITM3 and susceptibility to respiratory viral infections in the community. J Infect Dis 2013 1.06
75 Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties. J Transl Med 2009 1.05
76 European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997-2009). J Antimicrob Chemother 2011 1.04
77 Clinical influences on antibiotic prescribing decisions for lower respiratory tract infection: a nine country qualitative study of variation in care. BMJ Open 2012 1.03
78 Early intestinal Bacteroides fragilis colonisation and development of asthma. BMC Pulm Med 2008 1.02
79 Antibiotic consumption in southern and eastern Mediterranean hospitals: results from the ARMed project. J Antimicrob Chemother 2008 1.01
80 The antibiotic resistance and prescribing in European Children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide. Pediatr Infect Dis J 2013 0.99
81 Diagnosing pneumonia in patients with acute cough: clinical judgment compared to chest radiography. Eur Respir J 2013 0.99
82 European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe (1997-2009). J Antimicrob Chemother 2011 0.99
83 Treatment of acute cough/lower respiratory tract infection by antibiotic class and associated outcomes: a 13 European country observational study in primary care. J Antimicrob Chemother 2010 0.99
84 Reporter gene-expressing bone marrow-derived stromal cells are immune-tolerated following implantation in the central nervous system of syngeneic immunocompetent mice. BMC Biotechnol 2009 0.98
85 Clinical potential of intravenous neural stem cell delivery for treatment of neuroinflammatory disease in mice? Cell Transplant 2010 0.98
86 Unusual resistance patterns in macrolide-resistant Streptococcus pyogenes harbouring erm(A). J Antimicrob Chemother 2008 0.98
87 Evaluation of molecular assays for rapid detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2010 0.97
88 Antimicrobial-resistant pathogens in animals and man: prescribing, practices and policies. J Antimicrob Chemother 2010 0.97
89 European Surveillance of Antimicrobial Consumption (ESAC): outpatient use of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in Europe (1997-2009). J Antimicrob Chemother 2011 0.97
90 Oropharyngeal carriage of macrolide-resistant viridans group streptococci: a prevalence study among healthy adults in Belgium. J Antimicrob Chemother 2004 0.97
91 European Surveillance of Antibiotic Consumption (ESAC) point prevalence survey 2008: paediatric antimicrobial prescribing in 32 hospitals of 21 European countries. J Antimicrob Chemother 2010 0.96
92 European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe (1997-2009). J Antimicrob Chemother 2011 0.96
93 Employing whole genome mapping for optimal de novo assembly of bacterial genomes. BMC Res Notes 2014 0.96
94 Delayed antibiotic prescribing and associated antibiotic consumption in adults with acute cough. Br J Gen Pract 2012 0.96
95 Antimicrobial prescribing in European nursing homes. J Antimicrob Chemother 2011 0.95
96 European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe. J Antimicrob Chemother 2006 0.95
97 Outpatient antibiotic use in the four administrations of the UK: cross-sectional and longitudinal analysis. J Antimicrob Chemother 2008 0.94
98 Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin. J Antimicrob Chemother 2009 0.94
99 Exposure to antibacterial agents with QT liability in 14 European countries: trends over an 8-year period. Br J Clin Pharmacol 2008 0.92
100 European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe. J Antimicrob Chemother 2006 0.91
101 Complete Genome Sequences of Nitrofurantoin-Sensitive and -Resistant Escherichia coli ST540 and ST2747 Strains. Genome Announc 2014 0.90
102 Amoxicillin for acute lower respiratory tract infection in primary care: subgroup analysis of potential high-risk groups. Br J Gen Pract 2014 0.89
103 Antimicrobial drug use and macrolide-resistant Streptococcus pyogenes, Belgium. Emerg Infect Dis 2012 0.88
104 Quantitative and phenotypic analysis of mesenchymal stromal cell graft survival and recognition by microglia and astrocytes in mouse brain. Immunobiology 2012 0.88
105 Active liquid degassing in microfluidic systems. Lab Chip 2013 0.88
106 mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients. AIDS 2012 0.88
107 A longitudinal analysis on the association between antibiotic use, intestinal microflora, and wheezing during the first year of life. J Asthma 2008 0.88
108 European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe. J Antimicrob Chemother 2006 0.88
109 Interspecies recombination occurs frequently in quinolone resistance-determining regions of clinical isolates of Streptococcus pyogenes. Antimicrob Agents Chemother 2008 0.88
110 Increase in fluoroquinolone non-susceptibility among clinical Streptococcus pyogenes in Belgium during 2007-10. J Antimicrob Chemother 2012 0.88
111 Increasing telithromycin resistance among Streptococcus pyogenes in Europe. J Antimicrob Chemother 2008 0.87
112 Allogeneic stromal cell implantation in brain tissue leads to robust microglial activation. Immunol Cell Biol 2009 0.87
113 Cell type-associated differences in migration, survival, and immunogenicity following grafting in CNS tissue. Cell Transplant 2012 0.87
114 Surveillance of meningococcal infections in Belgium. Clin Microbiol Infect 1998 0.87
115 Autologous antibody capture to enrich immunogenic viruses for viral discovery. PLoS One 2013 0.86
116 Medication use in European primary care patients with lower respiratory tract infection: an observational study. Br J Gen Pract 2014 0.86
117 The more antibacterial trade names, the more consumption of antibacterials: a European study. Clin Infect Dis 2005 0.86
118 The first complete genome sequences of clinical isolates of human coronavirus 229E. Virus Genes 2012 0.85
119 Comparison of three Legionella urinary antigen assays during an outbreak of legionellosis in Belgium. J Med Microbiol 2005 0.84
120 Whole genome mapping as a fast-track tool to assess genomic stability of sequenced Staphylococcus aureus strains. BMC Res Notes 2014 0.84
121 Genotypic diversity, antimicrobial resistance, and virulence factors of human isolates and probiotic cultures constituting two intraspecific groups of Enterococcus faecium isolates. Appl Environ Microbiol 2008 0.84
122 Bacteraemia in Europe--antimicrobial susceptibility data from the MYSTIC surveillance programme. Int J Antimicrob Agents 2004 0.84
123 Indications for antimicrobial prescribing in European nursing homes: results from a point prevalence survey. Pharmacoepidemiol Drug Saf 2012 0.84
124 European Surveillance of Antimicrobial Consumption (ESAC): outpatient parenteral antibiotic treatment in Europe. J Antimicrob Chemother 2009 0.84
125 3-monthly azithromycin administration for trachoma. Lancet 2009 0.84
126 Antibiotics for respiratory tract infections in primary care. BMJ 2007 0.83
127 A point prevalence survey of antibiotic prescriptions: benchmarking and patterns of use. Br J Clin Pharmacol 2011 0.83
128 Spatiotemporal evolution of early innate immune responses triggered by neural stem cell grafting. Stem Cell Res Ther 2012 0.83
129 Safety assessment of Lactobacillus strains: presence of putative risk factors in faecal, blood and probiotic isolates. Int J Food Microbiol 2007 0.82
130 Presentation, antibiotic management and associated outcome in Polish adults presenting with acute cough/LRTI. Fam Pract 2011 0.82
131 The added diagnostic value of five different C-reactive protein point-of-care test devices in detecting pneumonia in primary care: A nested case-control study. Scand J Clin Lab Invest 2015 0.81
132 European Surveillance of Antimicrobial Consumption (ESAC): outpatient systemic antimycotic and antifungal use in Europe. J Antimicrob Chemother 2010 0.80
133 Sensitivity of detection of rhinoviruses in spiked clinical samples by nucleic acid sequence-based amplification in the presence of an internal control. J Microbiol Methods 2005 0.80
134 Building an international network for a primary care research program: reflections on challenges and solutions in the set-up and delivery of a prospective observational study of acute cough in 13 European countries. BMC Fam Pract 2011 0.80
135 Integrated DNA and RNA extraction and purification on an automated microfluidic cassette from bacterial and viral pathogens causing community-acquired lower respiratory tract infections. Lab Chip 2014 0.79
136 Clinical and microbiological impact of discontinuation of fluoroquinolone prophylaxis in patients with prolonged profound neutropenia. Eur J Haematol 2014 0.79
137 Infectivity of Lactobacillus rhamnosus and Lactobacillus paracasei isolates in a rat model of experimental endocarditis. J Med Microbiol 2007 0.79
138 Circulating dendritic cells of multiple sclerosis patients are proinflammatory and their frequency is correlated with MS-associated genetic risk factors. Mult Scler 2013 0.79
139 Incidental chest radiographic findings in adult patients with acute cough. Ann Fam Med 2012 0.79
140 Analysing the composition of outpatient antibiotic use: a tutorial on compositional data analysis. J Antimicrob Chemother 2011 0.78
141 Characterization of two new CTX-M-25-group extended-spectrum β-lactamase variants identified in Escherichia coli isolates from Israel. PLoS One 2012 0.78
142 Application of mixed-effects models to study the country-specific outpatient antibiotic use in Europe: a tutorial on longitudinal data analysis. J Antimicrob Chemother 2011 0.78
143 Outpatient systemic antimycotic and antifungal use in Europe: new outcome measure provides new insight. Int J Antimicrob Agents 2013 0.78
144 Nosocomial acquisition of methicillin-resistant Staphyloccocus aureus (MRSA) and extended-spectrum beta-lactamase (ESBL) Enterobacteriaceae in hospitalised patients: a prospective multicenter study. BMC Infect Dis 2012 0.77
145 Distinct in vitro properties of embryonic and extraembryonic fibroblast-like cells are reflected in their in vivo behavior following grafting in the adult mouse brain. Cell Transplant 2013 0.77
146 Histological characterization and quantification of cellular events following neural and fibroblast(-like) stem cell grafting in healthy and demyelinated CNS tissue. Methods Mol Biol 2014 0.77
147 Drug utilization 75% (DU75%) in 17 European hospitals (2000-2005): results from the ESAC-2 Hospital Care Sub Project. Curr Clin Pharmacol 2011 0.77
148 Culturing of respiratory viruses in well-differentiated pseudostratified human airway epithelium as a tool to detect unknown viruses. Influenza Other Respir Viruses 2014 0.77
149 Early Inflammatory Responses Following Cell Grafting in the CNS Trigger Activation of the Subventricular Zone: A Proposed Model of Sequential Cellular Events. Cell Transplant 2014 0.77
150 Implementation of e-Bug in Belgium. J Antimicrob Chemother 2011 0.77
151 Mass azithromycin distribution and emerging resistance: taking a minimum harms approach. Clin Infect Dis 2013 0.77
152 HPV vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against HPV-positive tumour cells. J Cell Mol Med 2014 0.77
153 Factors influencing inappropriate antibiotic prescription in Europe. Educ Prim Care 2013 0.77
154 Comment on: Can mass media campaigns change antimicrobial prescribing? A regional evaluation study. J Antimicrob Chemother 2007 0.76
155 European Surveillance of Antimicrobial Consumption (ESAC): systemic antiviral use in Europe. J Antimicrob Chemother 2011 0.76
156 Parenteral versus oral administration of systemic antimicrobials in European nursing homes: a point-prevalence survey. Drugs Aging 2011 0.76
157 Cytomegalovirus seropositivity is associated with herpes zoster. Hum Vaccin Immunother 2015 0.76
158 Induction of cytomegalovirus-specific T cell responses in healthy volunteers and allogeneic stem cell recipients using vaccination with messenger RNA-transfected dendritic cells. Transplantation 2015 0.75
159 Comment on: Developments in outpatient parenteral antimicrobial therapy (OPAT) for Gram-positive infections in Europe, and the potential impact of daptomycin. J Antimicrob Chemother 2009 0.75
160 Novel rapid culture-based detection method for methicillin-resistant Staphylococcus [corrected] aureus. J Clin Microbiol 2008 0.75
161 Coverage of the expanded program on immunization in Vietnam: Results from 2 cluster surveys and routine reports. Hum Vaccin Immunother 2015 0.75
162 Cost effectiveness of amoxicillin for lower respiratory tract infections in primary care: an economic evaluation accounting for the cost of antimicrobial resistance. Br J Gen Pract 2016 0.75
163 Predicting the presence of bacterial pathogens in the airways of primary care patients with acute cough. CMAJ 2016 0.75
164 Airway obstruction and bronchodilator responsiveness in adults with acute cough. Ann Fam Med 2012 0.75
165 Patient and prescriber determinants for the choice between amoxicillin and broader-spectrum antibiotics: a nationwide prescription-level analysis. J Antimicrob Chemother 2013 0.75
166 Shout about the European Union's success. Nature 2017 0.75
167 Cefepime and mortality: a real issue? Scand J Infect Dis 2010 0.75
168 Spatially explicit prioritization of human antibiotics and antineoplastics in Europe. Environ Int 2012 0.75
169 Antimicrobial prescribing in hospitalized adults stratified by age: data from the ESAC point-prevalence surveys. Drugs Aging 2012 0.75
170 Point prevalence survey on antibiotic use in a Croatian Infectious Disease Hospital. J Chemother 2013 0.75
171 Efficacy of Lactobacillus casei Shirota for patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 2016 0.75
172 Cefepime and mortality. Lancet Infect Dis 2009 0.75